Deep transfer learning approaches for Monkeypox disease diagnosis.

Monkeypox has become a significant global challenge as the number of cases increases daily. Those infected with the disease often display various skin symptoms and can spread the infection through contamination. Recently, Machine Learning (ML) has shown potential in image-based diagnoses, such as detecting cancer, identifying tumor cells, and identifying coronavirus disease (COVID)-19 patients. Thus, ML could potentially be used to diagnose Monkeypox as well. In this study, we developed a Monkeypox diagnosis model using Generalization and Regularization-based Transfer Learning approaches (GRA-TLA) for binary and multiclass classification. We tested our proposed approach on ten different convolutional Neural Network (CNN) models in three separate studies. The preliminary computational results showed that our proposed approach, combined with Extreme Inception (Xception), was able to distinguish between individuals with and without Monkeypox with an accuracy ranging from 77% to 88% in Studies One and Two, while Residual Network (ResNet)-101 had the best performance for multiclass classification in Study Three, with an accuracy ranging from 84% to 99%. In addition, we found that our proposed approach was computationally efficient compared to existing TL approaches in terms of the number of parameters (NP) and Floating-Point Operations per Second (FLOPs) required. We also used Local Interpretable Model-Agnostic Explanations (LIME) to explain our model's predictions and feature extractions, providing a deeper understanding of the specific features that may indicate the onset of Monkeypox.

Repositioning Vitamin C as a Promising Option to Alleviate Complications associated with COVID-19.

Vitamin C, also known as L-ascorbic acid, is an essential vitamin with pleiotropic functions, ranging from antioxidant to anti-microbial functions. Evidence suggests that vitamin C acts against inflammation, oxidative stress, autophagy chaos, and immune dysfunction. The ability to activate and enhance the immune system makes this versatile vitamin a prospective therapeutic agent amid the current situation of coronavirus disease 2019 (COVID-19). Being highly effective against the influenza virus, causing the common cold, vitamin C may also function against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its associated complications. Severe infections need higher doses of the vitamin to compensate for the augmented inflammatory response and metabolic demand that commonly occur during COVID-19. Compelling evidence also suggests that a high dose of vitamin C (1.5 g/kg body weight) in inflammatory conditions can result in effective clinical outcomes and thus can be employed to combat COVID-19. However, further studies are crucial to delineate the mechanism underlying the action of vitamin C against COVID-19. The current review aims to reposition vitamin C as an alternative approach for alleviating COVID-19-associated complications.

Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative pathogen of deadly Coronavirus disease-19 (COVID-19) pandemic, which emerged as a major threat to public health across the world. Although there is no clear gender or socioeconomic discrimination in the incidence of COVID-19, individuals who are older adults and/or with comorbidities and compromised immunity have a relatively higher risk of contracting this disease. Since no specific drug has yet been discovered, strengthening immunity along with maintaining a healthy living is the best way to survive this disease. As a healthy practice, calorie restriction in the form of intermittent fasting (IF) in several clinical settings has been reported to promote several health benefits, including priming of the immune response. This dietary restriction also activates autophagy, a cell surveillance system that boosts up immunity. With these prevailing significance in priming host defense, IF could be a potential strategy amid this outbreak to fighting off SARS-CoV-2 infection. Currently, no review so far available proposing IF as an encouraging strategy in the prevention of COVID-19. A comprehensive review has therefore been planned to highlight the beneficial role of fasting in immunity and autophagy, that underlie the possible defense against SARS-CoV-2 infection. The COVID-19 pathogenesis and its impact on host immune response have also been briefly outlined. This review aimed at revisiting the immunomodulatory potential of IF that may constitute a promising preventive approach against COVID-19.